ACCENTIA BIOPHARMACEUTICALS INC·4

Jun 19, 5:05 PM ET

RYLL TIMOTHY D 4

4 · ACCENTIA BIOPHARMACEUTICALS INC · Filed Jun 19, 2007

Insider Transaction Report

Form 4
Period: 2007-06-15
Transactions
  • Award

    Common Stock Warrant (right to buy)

    2007-06-15+2,000,0002,000,000 total(indirect: By LLC)
    Exercise: $4.32From: 2007-06-15Exp: 2011-06-14Common Stock (2,000,000 underlying)
  • Award

    Common Stock Warrant (right to buy)

    2007-06-15+200,000200,000 total(indirect: By MOAB Investment, LP)
    Exercise: $4.32From: 2007-06-15Exp: 2011-06-14Common Stock (200,000 underlying)
Footnotes (3)
  • [F1]Represents transaction(s) by MOAB Investments, LP. Mr. Ryll is the sole shareholder and sole director of MOAB Management Company, Inc., which is the sole general partner of MOAB Investments, LP. Mr. Ryll disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
  • [F2]Represents transaction(s) by Hopkins Capital Group II, LLC (HCG II). MOAB Investments, LP is a member of HCG II. Mr. Ryll is the sole shareholder and sole director of MOAB Management Company, Inc., which is the sole general partner of MOAB Investments, LP. Mr. Ryll disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
  • [F3]Represents warrants granted in consideration of personal guarantees and/or personal asset pledges by the reporting person to secure and support the issuer's credit factilities

Documents

1 file
  • 4
    rrd163410.xmlPrimary

    FORM 4